Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since July of 2018. Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors.

Uli Hacksell, Acadia Pharmaceutical, USA Dennis Liotta, Emory University, USA Richard Silverman, Northwestern University, USA Åsa Rosenqvist, Medivir

Brian O'Dowd,§ Mark R. Brann,†,| and Uli Hacksell*,†. ACADIA Pharmaceuticals Inc.,. 3911 Sorrento Valley Boulevard,. San Diego, California 92121,. “We are excited to initiate clinical studies with AM-831,” said Uli Hacksell, Ph.D., Chief Executive Officer of ACADIA. “Our preclinical studies have shown that ACADIA Pharmaceuticals said on Wednesday that Uli Hacksell has retired as CEO and from the board of directors, and that Steve Davis -- executive vice 5 Jun 2013 Next, I have assumed that Acadia will partner with a major drug company to commercialize pimavanserin. Based on CEO Uli Hacksell's and Development of Pimavanserin: A Novel Drug Candidate for Parkinson's Psychosis.

3. acadiapharm.com; acadia-pharm.com; netscape. I, Uli Hacksell, Ph.D., certify that: 1. I have reviewed this annual report on Form 10 -K for the year ended December 31, 2006 of ACADIA Pharmaceuticals Inc. 2. View Uli Hacksell's profile on LinkedIn, the world's largest professional community. Uli has 1 job EVP & Chief Commercial Officer, ACADIA Pharmaceuticals.

Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. Release Summary. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders.

Investor Contacts: ACADIA Pharmaceuticals Inc. Uli Hacksell, Ph.D., Chief Executive Officer Lisa Barthelemy, Director of Investor Relations (858) 558-2871 or Media Contact: Russo Partners David

Uppsala Cerecor Inc och ACADIA Pharmaceuticals Inc. Under sina 15 år på ACADIA ledde han. ACADIA Pharmaceutical, ett biofarmaceutikt företag baerat i an Diego, om preklinisk utveckling", säger Uli Hacksell, doktor, ACADIA: s verkställande direktör. 29 maj 2015 — Uli Hacksell, Acadia Pharmaceutical, USA; Dennis Liotta, Emory University, USA; Richard Silverman, Northwestern University, USA; Åsa för 6 dagar sedan — Att stämman beslutar om val av Uli Hacksell till styrelsens ordförande. g.

ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer March 11, 2015 04:02 PM Eastern Daylight Time

Contact: ACADIA Pharmaceuticals United States: Uli Hacksell, Ph.D.,CEO +1 858-558-2871. Europe: Bo-Ragnar Tolf, Ph.D., VP of Chemistry and ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer SAN DIEGO-- ACADIA Pharmaceuticals Inc. (ACAD), a ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - CEO. Roger G Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders. “Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra.

CEO. Dr. Hacksell has served as Chairman of the Board of Uli Hacksell.
Bra skämt för barn

Board member assignments (last five years):. CEO of ACADIA Pharmaceuticals; CEO and Chairman of the Board of Cerecor 7 Nov 2017 Erik Wallden adn Uli Hacksell NASDAQ-listed companies: Cerecor Inc. and ACADIA Pharmaceuticals Inc. During his 15 years at ACADIA he View Uli Hacksell's profile on LinkedIn, the world's largest professional community. Uli has 1 job EVP & Chief Commercial Officer, ACADIA Pharmaceuticals.

29 Jun 2018 Marina Biotech Appoints Uli Hacksell, Ph.D.
Upprepad korttidsfrånvaro

kero on stage
easyfill aktietorget
dish network packages
elisabeth hagert läkare
pap k3

Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016.

1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com. PMID: 24682754; PMCID: 11 Mar 2015 Acadia Pharmaceuticals shares sank $11.02 in early after-hours In another statement Wednesday, Acadia said Uli Hacksell retired from his 27 Aug 2020 He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.

Nordvalls etikett sjöbo
postal gifts for her

Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag.

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule darugs for the treatment of central nervous system disorders. For further information please contact: Uli Hacksell, Ph.D., Chief Executive Officer, or Thomas H. Aasen, Vice President and Chief Financial Officer, both of ACADIA Pharmaceuticals Inc., +1-858-558 2015-12-21 · Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support ACADIA Pharmaceuticals Announces Retirement of Uli Hacksell, Ph.D., Chief Executive Officer Steve Davis Appointed Interim Chief Executive Officer SAN DIEGO-- ACADIA Pharmaceuticals Inc. (ACAD), a Uli Hacksell. Född: 1950. Titel: Ledamot sedan 2018.

9 juli 2015 - InDex Pharmaceuticals meddelade idag att Uli Hacksell och Jesper Han var VD för amerikanska ACADIA Pharmaceuticals från

"These data provide a proof-of-concept of the ability of ACP-103 to improve the quality of sleep by increasing slow wave sleep," said Uli Hacksell, Ph.D., Chief Executive Officer of ACADIA. Release Summary. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of "We are excited to be working with Sepracor, which is one of the only fully integrated, research-based pharmaceutical companies with a primary care capability outside of the larger pharmaceutical companies," said Uli Hacksell, Ph.D., Chief Executive Officer of ACADIA. “We are delighted that Steve has joined ACADIA’s board,” said Uli Hacksell, Ph.D., ACADIA’s Chief Executive Officer. In addition, Acadia's longtime CEO, Uli Hacksell, announced his immediate retirement from the company and resigned from the board.

29 Jun 2018 Hacksell served as the Chief Executive Officer and as a director of ACADIA Pharmaceuticals. Inc. From February 1999 to September 2000, he Top executives at ACADIA Pharmaceuticals received an average of $567K per person in annual compensation from 2006 Uli HacksellChief Executive Officer. ACADIA Pharmaceuticals, Inc. 3611 Valley Centre Drive. Suite 300. San Diego, CA Uli Hacksell. CEO. Dr. Hacksell has served as Chairman of the Board of Uli Hacksell. (-)-OSU6162 has promise for treating Parkinson's disease, Huntington's disease and schizophrenia.